As of 2025-02-12, the Relative Valuation of Abbvie Inc (ABBV) is 115.13 USD. This relative valuation is based on P/E multiples. With the latest stock price at 191.83 USD, the upside of Abbvie Inc based on Relative Valuation is -40.0%.
The range of the Relative Valuation is 73.16 - 148.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.2x - 30.7x | 30.6x |
| Forward P/E multiples | 27.5x - 40.3x | 38.5x |
| Fair Price | 73.16 - 148.34 | 115.13 |
| Upside | -61.9% - -22.7% | -40.0% |
| Date | P/E |
| 2025-02-11 | 66.18 |
| 2025-02-10 | 65.67 |
| 2025-02-07 | 65.76 |
| 2025-02-06 | 66.58 |
| 2025-02-05 | 66.16 |
| 2025-02-04 | 65.53 |
| 2025-02-03 | 65.60 |
| 2025-01-31 | 63.45 |
| 2025-01-30 | 60.60 |
| 2025-01-29 | 60.47 |
| 2025-01-28 | 60.31 |
| 2025-01-27 | 61.03 |
| 2025-01-24 | 58.76 |
| 2025-01-23 | 58.88 |
| 2025-01-22 | 58.38 |
| 2025-01-21 | 59.55 |
| 2025-01-17 | 59.19 |
| 2025-01-16 | 59.93 |
| 2025-01-15 | 59.12 |
| 2025-01-14 | 60.57 |
| 2025-01-13 | 60.98 |
| 2025-01-10 | 60.44 |
| 2025-01-08 | 61.58 |
| 2025-01-07 | 61.94 |
| 2025-01-06 | 62.14 |
| 2025-01-03 | 62.52 |
| 2025-01-02 | 61.91 |
| 2024-12-31 | 61.31 |
| 2024-12-30 | 60.79 |
| 2024-12-27 | 61.42 |
| 2024-12-26 | 61.83 |
| 2024-12-24 | 62.10 |
| 2024-12-23 | 61.55 |
| 2024-12-20 | 60.58 |
| 2024-12-19 | 59.18 |
| 2024-12-18 | 59.69 |
| 2024-12-17 | 60.51 |
| 2024-12-16 | 59.21 |
| 2024-12-13 | 59.81 |
| 2024-12-12 | 59.75 |
| 2024-12-11 | 60.16 |
| 2024-12-10 | 60.61 |
| 2024-12-09 | 60.92 |
| 2024-12-06 | 60.79 |
| 2024-12-05 | 60.78 |
| 2024-12-04 | 60.88 |
| 2024-12-03 | 62.62 |
| 2024-12-02 | 62.71 |
| 2024-11-29 | 63.11 |
| 2024-11-27 | 63.16 |